AU2001239625A1 - Method of preparing solid dispersions - Google Patents

Method of preparing solid dispersions

Info

Publication number
AU2001239625A1
AU2001239625A1 AU2001239625A AU3962501A AU2001239625A1 AU 2001239625 A1 AU2001239625 A1 AU 2001239625A1 AU 2001239625 A AU2001239625 A AU 2001239625A AU 3962501 A AU3962501 A AU 3962501A AU 2001239625 A1 AU2001239625 A1 AU 2001239625A1
Authority
AU
Australia
Prior art keywords
methods
solid dispersions
substances
preparing solid
dispersions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239625A
Other languages
English (en)
Inventor
Arne Brodin
Sylvan Frank
Chao Ye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0000934A external-priority patent/SE0000934D0/xx
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001239625A1 publication Critical patent/AU2001239625A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AU2001239625A 2000-03-09 2001-03-08 Method of preparing solid dispersions Abandoned AU2001239625A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18798400P 2000-03-09 2000-03-09
US60187984 2000-03-09
SE0000934 2000-03-21
SE0000934A SE0000934D0 (sv) 2000-03-21 2000-03-21 Method of preparing pharmaceutical compositions
PCT/SE2001/000499 WO2001066091A1 (en) 2000-03-09 2001-03-08 Method of preparing solid dispersions

Publications (1)

Publication Number Publication Date
AU2001239625A1 true AU2001239625A1 (en) 2001-09-17

Family

ID=26655029

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239625A Abandoned AU2001239625A1 (en) 2000-03-09 2001-03-08 Method of preparing solid dispersions

Country Status (11)

Country Link
US (1) US20030104065A1 (de)
EP (1) EP1263413B1 (de)
JP (1) JP2003525895A (de)
AT (1) ATE326949T1 (de)
AU (1) AU2001239625A1 (de)
CY (1) CY1105515T1 (de)
DE (1) DE60119905T2 (de)
DK (1) DK1263413T3 (de)
ES (1) ES2263600T3 (de)
PT (1) PT1263413E (de)
WO (1) WO2001066091A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
DE10358749A1 (de) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform zur Bekämpfung von primären Kopfschmerzen
WO2007009164A1 (en) 2005-07-15 2007-01-25 Eiffel Technologies Limited Method of particle formation
WO2009011584A2 (en) * 2007-07-18 2009-01-22 Feyecon Development & Implementation B.V. A method of preparing a pharmaceutical co-crystal composition
DK2436383T3 (en) * 2009-05-29 2017-10-23 Morishita Jintan Co ORAL MEDICAL COMPOSITION AND ORAL MEDICAL Capsule WITH THE COMPOSITION CONCERNED
DK2683359T3 (en) * 2011-03-07 2015-07-20 3M Innovative Properties Co MICROWAVE DEVICES AND METHODS
FR2987266B1 (fr) * 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
CN108096195B (zh) * 2018-01-08 2020-01-24 中国药科大学 超临界抗溶剂法制备阿齐沙坦固体分散体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169433A (en) * 1990-07-18 1992-12-08 Formulogics, Inc. Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
SI9400079B (sl) * 1994-02-15 2003-02-28 Dr. Weidner Eckhard, Dipl. Ing. Postopek in naprava za pridobivanje in frakcioniranje majhnih delcev iz raztopin nasičenih s plinom
CN1233169A (zh) * 1996-10-14 1999-10-27 弗·哈夫曼-拉罗切有限公司 一种粉末状制剂的制备工艺
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
DK1071402T3 (da) * 1998-04-09 2007-02-19 Hoffmann La Roche Fremgangsmåde til af partikler med (sub)mikronstörrelse ved oplösning i komprimeret gas og overfladeaktive stoffer
ATE233549T1 (de) * 1998-06-19 2003-03-15 Skyepharma Canada Inc Neues verfahren zur herstellung von partikeln wasserunlöslicher komponenten im grössenbereich bis 2000 nm
US20020041898A1 (en) * 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents

Also Published As

Publication number Publication date
DK1263413T3 (da) 2006-09-11
PT1263413E (pt) 2006-08-31
EP1263413B1 (de) 2006-05-24
CY1105515T1 (el) 2010-07-28
ES2263600T3 (es) 2006-12-16
JP2003525895A (ja) 2003-09-02
EP1263413A1 (de) 2002-12-11
DE60119905T2 (de) 2007-01-11
ATE326949T1 (de) 2006-06-15
WO2001066091A1 (en) 2001-09-13
DE60119905D1 (de) 2006-06-29
US20030104065A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
WO2002000201A3 (en) Method for preparing a composition
CY1105515T1 (el) Μεθοδος παρασκευης στερεων διασπορων
CA2372339A1 (en) Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
WO2001089479A3 (en) Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
WO2001058412A3 (de) Extrakte von rückständen aus der weinherstellung
WO2005039551A3 (en) Solid pharmaceutical dosage form comprising an hiv protease inhibitor solid dispersion
WO2001070197A3 (en) Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
WO2002017885A3 (en) Controlled release formulation of erythromycin or a derivative thereof
WO2004071486B1 (en) Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
NO20056241L (no) Nanopartikler av polyoksyetylenerte derivater
CA2356959A1 (en) Water-insoluble drug delivery system
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
MY134340A (en) Pharmaceutical formulation having a masked taste and method for the production thereof
WO2006034147A3 (en) Compositions and methods for the preparation and administration of poorly water soluble drugs
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
WO2007144902A8 (en) Chewable bilayer tablet formulation
AU7795800A (en) Method for supercritical fluid extraction
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
DE60123447D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
WO2004026261A3 (en) Composition containing ribavirin and use thereof
WO2004096181A3 (en) Solid dosage form comprising desmopressin